MS Patient, Ph.D.: Pros and Cons of the First Generic DMT
The Copaxone patent expired on May 24, which could lead to cost-based DMT choice
The Copaxone patent expired on May 24, which could lead to cost-based DMT choice
This Memorial Day weekend marked not only the unofficial start of summer but also...
Drug Development, People